blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4229063

EP4229063 - NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  21.07.2023
Database last updated on 16.11.2024
FormerThe international publication has been made
Status updated on  30.04.2022
Most recent event   Tooltip02.11.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
TME Therapeutics LLC
3 Mossy Lane
Acton, MA 01720 / US
[2023/34]
Inventor(s)01 / PATEL, Vinod F.
Acton, Massachusetts 01720 / US
 [2023/34]
Representative(s)Synergy IP Group AG
Leonhardsgraben 52
Postfach
4001 Basel / CH
[N/P]
Former [2023/34]Pharma Patents International AG
Leonhardsgraben 52
Postfach
4001 Basel / CH
Application number, filing date21883717.719.10.2021
[2023/34]
WO2021US55651
Priority number, dateUS202063093705P19.10.2020         Original published format: US 202063093705 P
US202163253404P07.10.2021         Original published format: US 202163253404 P
[2023/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022086993
Date:28.04.2022
Language:EN
[2022/17]
Type: A1 Application with search report 
No.:EP4229063
Date:23.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.04.2022 takes the place of the publication of the European patent application.
[2023/34]
Search report(s)International search report - published on:US28.04.2022
ClassificationIPC:C07D487/04, C07D493/08
[2023/34]
CPC:
C07D487/04 (EP,US); A61P31/12 (EP); A61P31/16 (US);
A61P35/00 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/34]
TitleGerman:NEUARTIGE PIKFYVE-HEMMER UND VERFAHREN ZUR VERWENDUNG DAVON[2023/34]
English:NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME[2023/34]
French:NOUVEAUX INHIBITEURS DE LA PIKFYVE ET LEURS MÉTHODES D'UTILISATION[2023/34]
Entry into regional phase19.05.2023National basic fee paid 
19.05.2023Search fee paid 
19.05.2023Designation fee(s) paid 
19.05.2023Examination fee paid 
Examination procedure19.05.2023Examination requested  [2023/34]
13.12.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
31.10.2023Renewal fee patent year 03
31.10.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US4550166  (MORAN DANIEL B [US], et al);
 [A]US2004038993  (SHIPPS GERALD W [US], et al);
 [A]US2005176753  (BILODEAU MARK T [US], et al);
 [A]US2019315751  (SKERLJ RENATO T [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.